ARTICLE | Clinical News
HS-410: Additional Ph I/II data
January 6, 2017 9:37 PM UTC
Data from 94 patients with intermediate- or high-risk non-muscle invasive bladder cancer who have undergone transurethral resection of bladder tumor in the Phase II portion of a double-blind, U.S. Pha...
BCIQ Company Profiles
BCIQ Target Profiles